UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Interleukin Genetics, Inc.
____________________________________________________________
(Name of Issuer)
Common Stock, $.001 par value per share
____________________________________________________________
(Title of Class of Securities)
458738101
______________________________________
(CUSIP Number)
December 31, 2006
____________________________________________________________
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out
for a reporting person's initial filing on this form with
respect to the subject class of securities, and for any
subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover
page shall not be deemed to be "filed" for the purpose of
Section 18 of the Exchange Act or otherwise subject to the
liabilities of that section of the Exchange Act but shall be
subject to all other provisions of the Exchange Act
(however, see the Notes).
SCHEDULE 13G/A
------------------------------------------------------------
CUSIP No.: 458738101
------------------------------------------------------------
1 NAME OF REPORTING PERSON
Jeffrey K. Peterson
------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [_]
------------------------------------------------------------
3 SEC USE ONLY
------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
------------------------------------------------------------
5 SOLE VOTING POWER
2,136,148
NUMBER OF SHARES -----------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 0
EACH -----------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 2,136,148
WITH -----------------------------------
8 SHARED DISPOSITIVE POWER
0
------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,136,148
------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES [ ]
------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.85%
------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
------------------------------------------------------------
2
SCHEDULE 13G/A
------------------------------------------------------------
CUSIP No.: 458738101
Item 1.
(a) Name of Issuer:
Interleukin Genetics, Inc.
(b) Address of Issuer's Principal Executive Offices:
135 Beaver Street
Waltham, MA 02452
Item 2.
(a) Name of Person Filing:
Jeffrey K. Peterson
(b) Address of Principal Business Office or, if none,
Residence:
1707 Waldenmere Street
Sarasota, FL 34239
(c) Citizenship:
United States Citizen
(d) Title of Class of Securities:
Common Stock, $.001 par value per share (the
"Common Stock")
(e) CUSIP Number:
458738101
Item 3.
If this statement is filed pursuant to 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is
a: Not applicable
3
SCHEDULE 13G/A
------------------------------------------------------------
CUSIP No.: 458738101
Item 4. Ownership.
Provide the following information regarding the
aggregate number and percentage of the class of securities
of the issuer identified in Item 1.
(a) Amount beneficially owned:
As of December 31, 2006: Mr. Peterson was
the beneficial owner of 2,136,148 shares of
the issuer's Common Stock.
(b) Percent of class:
As of December 31, 2006: The 2,136,148
shares owned by Mr. Peterson constituted
7.85% of the shares outstanding.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Mr. Peterson has the sole power to vote or
direct the vote as to the 2,136,148 shares
owned by him.
(ii) Shared power to vote or to direct the vote:
N/A
(iii) Sole power to dispose or to direct the
disposition of:
Mr. Peterson has the sole power to dispose or
to direct the disposition of the 2,136,148
shares owned by him.
(iv) Shared power to dispose or to direct the
disposition of: N/A
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased
to be the beneficial owner of more than five percent of the
class of securities check the following.
Item 6. Ownership of More than Five Percent on Behalf of
Another Person.
Not applicable.
4
SCHEDULE 13G/A
------------------------------------------------------------
CUSIP No.: 458738101
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on by the
Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the
Group.
Not Applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
Dated: January 19, 2007
/s/ Jeffrey K. Peterson
__________________________________
Jeffrey K. Peterson